Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Hoelscher Paul W.. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Hoelscher Paul W. har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:HZNP / Horizon Therapeutics Plc EVP, CFO 36.424
US:RPHM / Reneo Pharmaceuticals, Inc. Director 35.000
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Hoelscher Paul W.. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Hoelscher Paul W. som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2022-04-22 2022-04-20 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -50.000 36.424 -57,85
2022-04-22 2022-04-20 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -21.542 1.049 -95,36 115,17 -2.480.992 120.813
2022-04-22 2022-04-20 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -28.458 22.591 -55,75 114,36 -3.254.457 2.583.507
2022-04-22 2022-04-20 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 50.000 51.049 4.766,44 22,14 1.107.000 1.130.225
2022-04-08 2022-04-06 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -185.060 86.424 -68,17
2022-04-08 2022-04-06 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -30.275 0 -100,00
2022-04-08 2022-04-06 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -91.710 66.673 -57,90 110,01 -10.089.026 7.334.703
2022-04-08 2022-04-06 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -215.335 1.049 -99,52 110,01 -23.688.788 115.399
2022-04-08 2022-04-06 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 185.060 216.384 590,79 22,14 4.097.228 4.790.742
2022-04-08 2022-04-06 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 30.275 31.324 2.886,08 15,96 483.189 499.931
2022-03-25 2022-03-25 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -663 158.383 -0,42 110,00 -72.930 17.422.130
2022-03-25 2022-03-24 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -1.481 159.046 -0,92 110,00 -162.910 17.495.060
2022-03-25 2022-03-23 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -26.090 30.275 -46,29
2022-03-25 2022-03-23 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -11.699 160.527 -6,79 110,01 -1.287.018 17.659.720
2022-03-25 2022-03-23 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -26.090 1.049 -96,13 110,00 -2.870.002 115.394
2022-03-25 2022-03-23 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 26.090 27.139 2.487,13 15,96 416.396 433.138
2022-03-25 2022-03-07 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift 172.226 172.226
2022-03-25 2022-03-07 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift -172.226 72.789 -70,29
2022-03-25 2022-03-07 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift 66.626 245.015 37,35
2022-03-25 2022-03-07 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift -66.626 1.049 -98,45
2022-01-24 2022-01-20 4 RPHM Reneo Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 35.000 35.000
2022-01-24 2022-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSUs)
M - Exercise -5.558 0 -100,00
2022-01-24 2022-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -2.463 67.675 -3,51 86,42 -212.852 5.848.474
2022-01-24 2022-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 5.558 70.138 8,61
2022-01-06 2022-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -11.642 23.286 -33,33
2022-01-06 2022-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -11.616 5.800 -66,70
2022-01-06 2022-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -11.067 11.069 -50,00
2022-01-06 2022-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -14.514 14.514 -50,00
2022-01-06 2022-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -17.983 0 -100,00
2022-01-06 2022-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -50.666 64.580 -43,96 101,84 -5.159.825 6.576.827
2022-01-06 2022-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
A - Award 47.375 115.246 69,80
2022-01-06 2022-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 66.822 67.871 6.370,07
2022-01-06 2022-01-04 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
A - Award 9.522 9.522
2021-12-30 2021-12-28 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -8.575 56.365 -13,20
2021-12-30 2021-12-28 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -8.575 1.049 -89,10 110,00 -943.250 115.390
2021-12-30 2021-12-28 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 8.575 9.624 817,45 15,96 136.857 153.599
2021-12-30 2021-12-03 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift -1.049 1.049 -50,00
2021-12-30 2021-08-25 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift 6.163 178.389 3,58
2021-12-30 2021-08-25 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift -6.163 2.098 -74,60
2021-07-30 2021-07-28 4 HZNP Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
A - Award 17.418 17.418
2021-07-30 2021-07-28 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -3.858 8.261 -31,83 102,50 -395.445 846.752
2021-07-30 2021-07-28 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
A - Award 8.708 12.119 255,29
2021-05-14 2021-05-14 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -102.925 172.226 -37,41 90,01 -9.263.847 15.501.339
2021-02-19 2021-02-17 4 HZNP Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
A - Award 17.416 17.416
2021-02-19 2021-02-17 4 HZNP Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
A - Award 4.718 4.718
2021-02-19 2021-02-17 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -1.045 2.362 -30,67 87,17 -91.093 205.896
2021-02-19 2021-02-17 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
A - Award 2.358 3.407 224,79
2021-02-19 2021-02-01 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift 3.094 275.151 1,14
2021-02-19 2021-02-01 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift -3.094 1.049 -74,68
2021-01-22 2021-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
M - Exercise -5.556 5.558 -49,99
2021-01-22 2021-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -2.462 4.143 -37,27 77,43 -190.633 320.792
2021-01-22 2021-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 5.556 6.605 529,65
2021-01-22 2021-01-19 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift 169.132 272.057 164,33
2021-01-22 2021-01-19 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift -169.132 1.049 -99,38
2021-01-06 2021-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -14.513 29.028 -33,33
2021-01-06 2021-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -65.696 0 -100,00
2021-01-06 2021-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -17.983 17.983 -50,00
2021-01-06 2021-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -134.698 170.181 -44,18 73,28 -9.870.669 12.470.864
2021-01-06 2021-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
A - Award 205.638 304.879 207,21
2021-01-06 2021-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 98.192 99.241 9.360,53
2021-01-06 2021-01-04 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
A - Award 34.928 34.928
2020-08-25 2020-08-24 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -1.823 102.925 -1,74 76,23 -138.967 7.845.973
2020-08-25 2020-08-24 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -27.753 104.748 -20,95 75,73 -2.101.735 7.932.566
2020-05-07 2020-05-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -104.994 132.501 -44,21 38,00 -3.989.772 5.035.038
2020-02-28 2020-02-26 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift 11.452 237.495 5,07
2020-02-28 2020-02-26 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift -11.452 0 -100,00
2020-02-21 2020-02-19 4 HZNP Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
A - Award 30.014 30.014
2020-02-21 2020-02-19 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -6.649 11.407 -36,82 36,06 -239.763 411.336
2020-02-21 2020-02-19 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
A - Award 15.007 18.056 492,19
2020-02-21 2020-02-14 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift 226.043 226.043
2020-02-21 2020-02-14 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift -226.043 3.049 -98,67
2020-01-23 2020-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
A - Award 11.114 11.114
2020-01-23 2020-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -2.461 229.137 -1,06 38,25 -94.133 8.764.490
2020-01-23 2020-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
A - Award 5.555 231.598 2,46
2020-01-07 2020-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -65.696 65.696 -50,00
2020-01-07 2020-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -17.982 35.966 -33,33
2020-01-07 2020-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -69.321 226.043 -23,47 36,10 -2.502.488 8.160.152
2020-01-07 2020-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
A - Award 72.376 295.364 32,46
2020-01-07 2020-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 83.678 222.988 60,07
2020-01-07 2020-01-03 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
A - Award 43.541 43.541
2019-10-17 2019-10-15 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -10.000 139.310 -6,70 28,00 -280.000 3.900.680
2019-10-17 2019-10-15 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -10.000 149.310 -6,28 28,01 -280.100 4.182.173
2019-09-04 2019-08-30 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -1.359 159.310 -0,85 28,00 -38.052 4.460.680
2019-08-23 2019-08-22 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -4.516 271.484 -1,64
2019-08-23 2019-08-22 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Options (Right to Buy)
M - Exercise -25.060 64.940 -27,84
2019-08-23 2019-08-22 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 4.516 160.669 2,89 22,14 99.984 3.557.212
2019-08-23 2019-08-22 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 25.060 156.153 19,12 15,96 399.958 2.492.202
2019-08-23 2019-08-21 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -14.201 131.093 -9,77 28,01 -397.770 3.671.915
2019-08-23 2019-08-21 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -56.702 145.294 -28,07 28,00 -1.587.656 4.068.232
2019-03-25 2019-03-23 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -31.000 0 -100,00
2019-03-25 2019-03-23 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -13.733 199.626 -6,44 26,84 -368.594 5.357.962
2019-03-25 2019-03-23 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 31.000 213.359 17,00
2019-02-22 2019-02-20 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -32.064 182.359 -14,95 21,54 -690.659 3.928.013
2019-02-22 2019-02-20 4 HZNP Horizon Pharma plc
Ordinary Shares
A - Award 72.375 214.423 50,95
2019-01-08 2019-01-05 4 HZNP Horizon Pharma plc
Restricted Stock Units (RSU)
M - Exercise -65.695 131.392 -33,33
2019-01-08 2019-01-05 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -29.419 142.048 -17,16 20,39 -599.853 2.896.359
2019-01-08 2019-01-05 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 65.695 171.467 62,11
2019-01-08 2019-01-04 4 HZNP Horizon Pharma plc
Restricted Stock Units (RSU)
A - Award 53.948 53.948
2018-06-25 2018-06-23 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -20.000 0 -100,00
2018-06-25 2018-06-23 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -8.860 105.772 -7,73 17,67 -156.556 1.868.991
2018-06-25 2018-06-23 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 20.000 114.632 21,13
2018-05-07 2018-05-03 4 HZNP Horizon Pharma plc
Restricted Stock Units (RSU)
A - Award 197.087 197.087
2018-03-27 2018-03-23 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -31.000 31.000 -50,00
2018-03-27 2018-03-23 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -13.733 92.262 -12,96 13,86 -190.339 1.278.751
2018-03-27 2018-03-23 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 31.000 105.995 41,34
2017-06-26 2017-06-23 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -20.000 20.000 -50,00
2017-06-26 2017-06-23 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -9.140 74.995 -10,86 11,73 -107.212 879.691
2017-06-26 2017-06-23 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 20.000 84.135 31,18
2017-03-24 2017-03-23 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -31.000 62.000 -33,33
2017-03-24 2017-03-23 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -14.167 62.707 -18,43 14,56 -206.272 913.014
2017-03-24 2017-03-23 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 31.000 76.874 67,58
2016-06-27 2016-06-23 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -20.000 40.000 -33,33
2016-06-27 2016-06-23 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -8.643 46.529 -15,67 17,44 -150.734 811.466
2016-06-27 2016-06-23 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 20.000 55.172 56,86
2016-03-24 2016-03-23 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -31.000 93.000 -25,00
2016-03-24 2016-03-23 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -9.641 33.721 -22,23 16,32 -157.341 550.327
2016-03-24 2016-03-23 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 31.000 43.362 250,77
2015-06-24 2015-06-23 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -20.000 60.000 -25,00
2015-06-24 2015-06-23 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -8.799 11.201 -44,00 34,27 -301.542 383.858
2015-06-24 2015-06-23 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 20.000 20.000
2015-05-08 2015-05-06 4 HZNP Horizon Pharma plc
Performance Share Units (PSU)
A - Award 699.000 699.000
2015-03-25 2015-03-23 4 HZNP Horizon Pharma plc
Performance Share Units (PSU)
A - Award 233.000 233.000
2015-03-25 2015-03-23 4 HZNP Horizon Pharma plc
Restricted Stock Units
A - Award 124.000 124.000
2015-03-25 2015-03-23 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
A - Award 276.000 276.000
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Restricted Stock Units
A - Award 80.000 80.000
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
A - Award 90.000 90.000
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Restricted Stock Units
D - Sale to Issuer -80.000 0 -100,00
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
D - Sale to Issuer -90.000 0 -100,00
2014-06-30 2014-06-27 4 HZNP HORIZON PHARMA, INC.
Restricted stock units
A - Award -80.000 80.000 -50,00
2014-06-30 2014-06-27 4 HZNP HORIZON PHARMA, INC.
Employee stock options (right to buy)
A - Award -90.000 90.000 -50,00
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)